News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GeneOhm Sciences, Inc. And The Cleveland Clinic Foundation Announce The Completion Of A Study On Thrombophilia Markers Using The ePlex Platform



10/19/2005 5:12:09 PM

GeneOhm Sciences, Inc. (GSI) today announced the completion of the first collaborative study between GSI and The Cleveland Clinic Foundation. This study focused on several Single Nucleotide Polymorphisms (SNPs) in genes associated with venous thromboembolism (VTE). Using GSI's proprietary ePlex(TM) platform, six markers were simultaneously genotyped in multiplex reactions and compared to results observed on the Roche LightCycler(R). Of 269 single-point genotypes, each platform exhibited 100% concordant results.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES